Treatment preferences in stage IA and IB testicular seminoma: multicenter study of Anatolian Society of Medical Oncology

Bilici, Ahmet; Ozturk, Turkan; Turkmen, Esma; Odabas, Hatice; Cihan, Sener; Selcukbiricik, Fatih; Erdogan, Bulent; Urakci, Zurat; Kandemir, Nurten; Bayoglu, Ibrahim; Demirci, Umut; Duran, Ayse; Sendur, Mehmet; Yavuzer, Dilek; Harputluoglu, Hakan; Kavgaci, HALİL; Gumus, Mahmut

doi:10.1007/s00345-015-1492-9

Treatment preferences in stage IA and IB testicular seminoma: multicenter study of Anatolian Society of Medical Oncology

Copy For Citation

Bilici A., Ozturk T., Turkmen E., Odabas H., Cihan S., Selcukbiricik F., ...More

WORLD JOURNAL OF UROLOGY, vol.33, no.10, pp.1613-1622, 2015 (SCI-Expanded)

Publication Type: Article / Article
Volume: 33 Issue: 10
Publication Date: 2015
Doi Number: 10.1007/s00345-015-1492-9
Journal Name: WORLD JOURNAL OF UROLOGY
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Page Numbers: pp.1613-1622
Karadeniz Technical University Affiliated: Yes

Abstract

Approximately 75 % of patients with testicular seminoma present with stage I disease, and the probability of long-term survival approaches 100 %. However, the standard adjuvant treatment for stage I seminoma patients remains controversial, and there is no uniform consensus in the literature. The present study was performed to evaluate treatment preference and outcomes for men with stage I testicular seminoma.